We concluded that the differences in clinicopathological features were associated with the clinical outcomes in "Stage Ⅰ -Ⅲ" when provided genetic testing for prognostication and therapy selection in breast cancer patients.
Source: https://t.co/D5Dx5sKMa7
The scientometric analysis presented the tendency in the BRCA research field over the past decade. Current research focuses on clinical trials of poly-adenosine diphosphate ribose polymerase inhibitors drugs and their resistance mechanisms.
Source: https://t.co/cP1eOmLpfD
Here we review the prevalence of allergy to peanut and tree nuts in different populations of the world; It's argued that nut-specific AIT may benefit from molecular subcutaneous AIT (SCIT) approaches.
https://t.co/6K4pg4HlmP
Carrier screening is a type of genetic test that can tell you whether you carry a gene for certain genetic disorders. Doing it before or during pregnancy allows you to determine your chances of having a child with a genetic disorder.
This review focuses on the development of immunoresistance in BCs. It discusses the strategies that can modulate the immune system and target breast CSCs directly to treat BC, including immunotherapy with immune checkpoint blockades.
Source: https://t.co/jwvdS1wmuP
As we come to the end of April 2023, we want to recognize it as the official National Cancer Control Month. During the rest of National Cancer Control Month and every month after, we can all join the movement to end cancer as we know it.
#NationalCancerControlMonth
Having children is a life-changing experience, and it is essential to understand the health of your children and unborn child for your family's future life. Genetic carrier screening helps provide awareness of personalized DNA makeup.
In this review, we will focus on the biomarker role of EV in NSCLC immunotherapy from various perspectives, including the definition and properties of EV, the biomarker role of EV in current NSCLC immunotherapy, and immunotherapy research
Source: https://t.co/CJRN8To1Ni
Focus on the possibility of integrating the know-how of micro-engineers, cancer immunologists, pharmaceutical researchers and bioinformaticians to meet the needs of cancer researchers and clinicians.
Source: https://t.co/NYpc6oXjo2
Early identification of patients who metabolize these drugs more rapidly or slowly than average could predict therapeutic effectivity and safety. Yet implementation of pharmacogenetics is progressing slowly.
Source: https://t.co/0yErTuiFf1
This study explored how demographic characteristics, life experiences, and firefighting exposures impact cancer among female firefighters and described the types and biological features of cancers as reported by women in the fire service.
SOurce: https://t.co/K5SXC2QZqE
To protect the rights and interests of doctors in the future and ensure the continuous operation of MDT. To strengthen the research on the diagnosis and treatment of pancreatic cancer, MDT can try the Internet +MDT mode to improve the efficiency of MDT.
https://t.co/XJZ17To8xQ
"They have weathered a pandemic, a rapidly changing industry with sudden strategic pivots. They have done so with a smile on their face to help improve the lives of our patients in whatever way Apollo can."
- Justin Leavitt, Co-Founder and Chief Financial Officer
By using bibliometrics, we conducted a comprehensive review of SB and PA in cancer related studies. The research focused on exercise and sedentariness in breast cancer patients and the role of PA in improving quality of life in survivorship.
Source: https://t.co/RvuskWxviQ
In all circumstances, ongoing dialog between cardiologists and clinical geneticists will be needed to accurately interpret genetic testing and improve these patients’ health. This may be most effective form testing for patients.
Source: https://t.co/jTKEf7Xmlr
The results of this study form a baseline for a future personalized prediction model based on machine learning in the domain of combined nanotechnology and phototherapy based cancer treatment.
#CancerTreatment#Health#PreventativeCare
Source: https://t.co/r23DEBebjd
Apollo is able to reference CGx and PGx testing for other labs while providing quick turn around times with easy to use results. To know more about our reference process, follow the link below. #GeneticTesting#Apollo#PGx#CGx
https://t.co/ZFAnxm65UH
Due to the current Public Health Emergency, Medicare will cover up to 8 OTC At-home Covid-19 testing kits per month for Medicare Part B Participants. Contact us or visit our website today to see if you qualify!
#ApolloHealthGroup#Covid-19 #AtHomeTest#Medicare